This page presents reports about trends and developments in the National Immunisation Programme. These reports are published annually. At the bottom of the page, there is an overview of other studies about the vaccinations in the National Immunisation Programme and the diseases we vaccinate against.
Every year, RIVM describes how many children have been vaccinated. This is called vaccination coverage. There are annual reports on vaccination coverage.
Vaccination coverage of the National Immunisation Programme in the Netherlands
- Vaccination coverage of the National Immunisation Programme in the Netherlands. Reporting year 2024 (link is external)
- Vaccination coverage and annual report of the National Immunisation Programme in the Netherlands – 2022 (Reporting year 2023) (link is external)
- Vaccination coverage and annual report of the National Immunisation Programme in the Netherlands – 2021 (Reporting year 2022) (link is external)
- Vaccination coverage and annual report of the National Immunisation Programme in the Netherlands – 2020 (Reporting year 2021) (link is external)
- Vaccination coverage and annual report of the National Immunisation Programme in the Netherlands – 2019 (Reporting year 2020) (link is external)
- Vaccination coverage and annual report of the National Immunisation Programme in the Netherlands – 2018 (Reporting year 2019) (link is external)
- Vaccination coverage and annual report of the National Immunisation Programme in the Netherlands – 2017 (Reporting year 2018) (link is external)
- Vaccination coverage and annual report of the National Immunisation Programme in the Netherlands – 2016 (Reporting year 2017) (link is external)
- Vaccination coverage and annual report of the National Immunisation Programme in the Netherlands – 2016 (Reporting year 2016) (link is external)
- Vaccination coverage and annual report of the National Immunisation Programme in the Netherlands – 2015 (Reporting year 2015) (link is external)
- Vaccination coverage and annual report of the National Immunisation Programme in the Netherlands – 2014 (Reporting year 2014) (link is external)
RIVM tracks how common infectious diseases are in the Netherlands and whether these diseases are changing over time. This is called surveillance. A report is published every year presenting the current state of affairs regarding the diseases covered by the National Immunisation Programme.
Surveillance report: full text in English, summary in Dutch
The surveillance report of the National Immunisation Programme is written in English. The report also includes a public information summary and extensive abstract that have been translated into Dutch.
The National Immunisation Programme in the Netherlands: Surveillance and developments
- The National Immunisation Programme in the Netherlands. Surveillance and developments in 2023-2024 (link is external)
- The National Immunisation Programme in the Netherlands. Surveillance and developments in 2022-2023 (link is external)
- The National Immunisation Programme in the Netherlands. Surveillance and developments in 2021-2022 (link is external)
- The National Immunisation Programme in the Netherlands. Surveillance and developments in 2020-2021 (link is external)
- The National Immunisation Programme in the Netherlands: Surveillance and developments in 2019-2020 (link is external)
- Het Rijksvaccinatieprogramma in Nederland: Surveillance en ontwikkelingen in 2018-2019 (Dutch summary of the surveillance report) (link is external)
- The National Immunisation Programme in the Netherlands: Surveillance and developments in 2018-2019 (link is external)
- Het Rijksvaccinatieprogramma in Nederland: Surveillance en ontwikkelingen in 2017-2018 (Dutch summary of the surveillance report) (link is external)
- The National Immunisation Programme in the Netherlands: Surveillance and developments in 2017-2018 (link is external)
- Het Rijksvaccinatieprogramma in Nederland: Surveillance en ontwikkelingen in 2017-2018 (Dutch summary of the surveillance report)
- The National Immunisation Programme in the Netherlands : Surveillance and developments in 2016-2017 (link is external)
- The National Immunisation Programme in the Netherlands : Surveillance and developments in 2015-2016 (link is external)
- The National Immunisation Programme in the Netherlands : Surveillance and developments in 2014-2015 (link is external)
- The National Immunisation Programme in the Netherlands : Surveillance and developments in 2013-2014 (link is external)
Lareb reporting
The Pharmacovigilance Centre Lareb keeps track of the side effects of all medicinal products in the Netherlands. These reports present the side effects reported about the vaccines used in the National Immunisation Programme.
Lareb – Possible side effects in the National Immunisation Programme
- Reported side effects in 2023 (in Dutch) (link is external)
- Reported side effects in 2022 (in Dutch) (link is external)
- Reported side effects in 2021 (in Dutch)
- Reported side effects in 2020 (in Dutch) (link is external)
- Reported side effects in 2019 (in Dutch) (link is external)
- Reported side effects in 2018 (in Dutch) (link is external)
- Reported side effects in 2017 (in Dutch) (link is external)
- Reported side effects in 2016 (in Dutch) (link is external)
- Reported side effects in 2015 (in Dutch) (link is external)
Different organisations around the globe research the infectious diseases that covered by the National Immunisation Programme. This includes the World Health Organization (WHO). Various international reports and studies are listed here.
World Health Organization position papers
- HPV (Cervical cancer) (link is external)
- Mumps (link is external)
- Diphtheria (link is external)
- Hepatitis B (link is external)
- Hib disease (link is external)
- Whooping cough (pertussis) (link is external)
- Measles (link is external)
- Meningococcal disease (link is external)
- Pneumococcal vaccination (link is external)
- Polio (link is external)
- Rubella (link is external)
- Tetanus (link is external)